In mouse PCa xenografts, IL-24 decreases the levels of secreted soluble clusterin (sCLU) protein, which is linked to resistance to chemotherapy and radiation and hormone therapies, leading to reduced tumor growth and angiogenesis [37]. The gene discussed is CLU; the disease is posterior cortical atrophy.